JPRN-UMIN000011776已完成1 期
A phase I/II study of weekly nab-Paclitaxel/Cisplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer - A phase I/II study of weekly nab-Paclitaxel/Cisplatin in NSCLC
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Interstitial pneumonia or pulmonary fibrosis detectable on CT scan 2)History of severe drug allergy 3)EGFR mutation positive, ALK rearrangement positive, other driver oncogenes positive 4)History of serious disease condition 5)Symptomatic brain metastasis 6)History of active double cancer 7)History of pregnancy or lactation 8)History of active psychological disease
研究者
相似试验
已完成
1 期
A Phase I Study of Weekly Nab-Paclitaxel/Carboplatin in Chemotherapy-Naive Patients with Advanced Non-Small-Cell Lung Cancerpreviously untreated advanced non-small cell lung cancerJPRN-UMIN000012788Department of Respiratory Medicine in Hyogo Prefectural Amagasaki Hospital30
已完成
2 期
A phase 2 study of weekly Nab-Paclitaxel followed by FEC (Fluorouracil, Epirubicin, Cyclophosphamide) as primary therapy for operable breast cancerBreast cancerJPRN-UMIN000007510ahanishi Clinic30
已完成
1 期
Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer (NJLCG1402)on-small cell lung cancerJPRN-UMIN000014893orth Japan Lung Cancer Study Group (NJLCG)42
招募中
不适用
Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Breast CancerBreast cancerJPRN-UMIN000005979Wakayama Medical University50
已完成
2 期
Phase II study of weekly nab-paclitaxel in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy.JPRN-UMIN000013390ational Hospital Organization Asahikawa Medical center40